Predictions
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.60
13.07.23
13.07.23
€65.28
13.07.24
13.07.24
-19.66%
08.07.24
08.07.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€113.58
13.07.24
13.07.24
-1.58%
10:07
10:07
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.89
13.07.23
13.07.23
€80.49
13.07.24
13.07.24
-23.70%
08:00
08:00
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€125.20
13.07.24
13.07.24
-1.58%
10:07
10:07
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€81.00
24.06.23
24.06.23
€100.00
31.12.25
31.12.25
-5.60%
12:25
12:25
Could be very worthwhile Investment >20% year
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.44
24.06.23
24.06.23
€100.00
31.07.25
31.07.25
-9.85%
10:07
10:07
Could be very worthwhile Investment >20% year
Chimerix Inc.
Start price
Target price
Perf. (%)
€1.19
24.06.23
24.06.23
€3.00
31.03.26
31.03.26
-36.06%
08.07.24
08.07.24
Could be very worthwhile Investment >20% year
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€38.49
24.06.23
24.06.23
€50.00
31.03.26
31.03.26
-44.14%
15:30
15:30
Could be very worthwhile Investment >20% year
Krystal Biotech
Start price
Target price
Perf. (%)
€105.00
24.06.23
24.06.23
€200.00
30.04.26
30.04.26
69.52%
13:57
13:57
Could be very worthwhile Investment >20% year
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€214.90
24.06.23
24.06.23
€380.00
31.05.26
31.05.26
23.69%
11:31
11:31
Could be very worthwhile Investment >20% year
Prothena Corp. plc
Start price
Target price
Perf. (%)
€62.00
24.06.23
24.06.23
€90.00
31.03.26
31.03.26
-69.84%
05.07.24
05.07.24
Could be very worthwhile Investment >20% year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€44.20
24.06.23
24.06.23
€60.00
31.12.25
31.12.25
-77.79%
04.07.24
04.07.24
Could be very worthwhile Investment >20% year
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€10.60
24.06.23
24.06.23
€20.00
31.12.25
31.12.25
-32.12%
08.07.24
08.07.24
Could be very worthwhile Investment >20% year
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€5.70
07.09.22
07.09.22
€10.00
31.12.24
31.12.24
7.90%
08.07.24
08.07.24
Could be very worthwhile Investment >20% year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€208.80
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
13.79%
09:40
09:40
Could be very worthwhile Investment >20% year
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.80
07.09.22
07.09.22
€50.00
31.12.25
31.12.25
9.40%
08.07.24
08.07.24
Could be very worthwhile Investment >20% year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€196.52
08.01.22
08.01.22
€915.00
14.01.27
14.01.27
130.00%
14:53
14:53
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€196.52
08.01.22
08.01.22
€915.00
14.01.27
14.01.27
130.00%
14:53
14:53
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€196.52
08.01.22
08.01.22
€915.00
14.01.27
14.01.27
130.00%
14:53
14:53
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
13.87%
15:30
15:30
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
13.87%
15:30
15:30
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
13.87%
15:30
15:30
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued